VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EDVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EDVAEndovia Health Sciences, Inc.
$0.19$3M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEDVAQuarterly Financials

Endovia Health Sciences, Inc. (EDVA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Endovia Health Sciences, Inc. (EDVA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EDVA Income Statement

Quarterly statement

EDVA Income Statement

Endovia Health Sciences, Inc. (EDVA) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue04.22K-365.21K00438.27K585.89K981.86K1.05M1.54M2.69M5.14M5.19M5.82M4.79M4.87M4.5M3.93M3.06M2.83M
Revenue Growth %--99.04%-162.33%-100%-100%-71.55%-78.21%-80.91%-79.85%-73.54%-43.89%5.62%15.47%48.29%56.49%72.26%36.84%62.41%146.53%180.05%
Cost of Goods Sold3.59K479.42K-412.55K201.26K37.02K468.71K929.5K690.84K802.35K1.38M1.96M3.85M5.42M4.06M1.53M3.72M3.83M3.09M2.72M2.01M
COGS % of Revenue-11349.91%112.96%--106.95%158.65%70.36%76.65%89.38%72.73%74.79%104.39%69.75%31.91%76.37%85.04%78.81%88.92%71%
Gross Profit-3.59K-475.2K47.34K-201.26K-37.02K-30.44K-343.61K291.02K244.43K163.62K733.25K1.3M-228.15K1.76M3.26M1.15M673.15K832K339.27K819.85K
Gross Margin %--11249.91%-12.96%---6.95%-58.65%29.64%23.35%10.62%27.27%25.21%-4.39%30.25%68.09%23.63%14.96%21.19%11.08%29%
Gross Profit Growth %90.3%-1460.94%113.78%-169.16%-115.14%-118.61%-146.86%-77.56%207.14%-90.71%-77.53%12.67%-133.89%111.72%861.68%40.4%-25.62%23.29%873.93%86.91%
Operating Expenses2M533.85K1.02M9.34M1.63M2M6.09M2.96M3.94M3.41M4.02M5.62M3.99M5.22M8.03M6.26M6.5M6.52M6.49M12.89M
OpEx % of Revenue-12638.59%-280.32%--456.82%1039.76%301.53%375.95%221.58%149.53%109.26%76.87%89.59%167.66%128.57%144.53%165.95%212%455.97%
Selling, General & Admin854.31K974.58K885.84K573.31K1.43M1.78M5.79M1.46M3.73M3.2M3.71M3.68M3.99M4.84M7.72M5.82M6.17M6.08M5.73M12.54M
SG&A % of Revenue-23072.47%-242.56%--406.71%988.5%149.11%356.74%207.38%138.07%71.44%76.87%83.04%161.21%119.58%137.25%154.95%187.07%443.44%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses1000K-440.73K137.91K1000K201.66K219.61K300.3K1000K201.04K218.83K308.17K1000K0381K308.94K438K327.3K431.55K1000K3.63K
Operating Income-2.01M-1.01M-976.41K-9.54M-1.63M-2.03M-6.44M-2.67M-3.69M-3.25M-3.29M-4.32M-4.22M-3.45M-4.77M-5.11M-5.83M-5.68M-6.15M-12.07M
Operating Margin %--23888.45%267.36%---463.76%-1098.41%-271.89%-352.6%-210.97%-122.26%-84.05%-81.26%-59.34%-99.56%-104.94%-129.57%-144.76%-200.92%-426.97%
Operating Income Growth %-22.96%50.36%84.83%-257.53%55.77%37.47%-95.79%38.25%12.57%5.92%31.1%15.41%27.58%39.22%22.45%57.66%13.1%-29.43%52.93%-426.07%
EBITDA-2M-1.01M-805.55K-9.51M-1.6M-2M-6.3M-2.53M-3.56M-3.12M-3.14M-4.18M-4.08M-3.32M-4.34M-5.06M-5.78M-4.35M-6.09M-11.94M
EBITDA Margin %--23833.5%220.58%---455.32%-1075.37%-258.14%-339.7%-202.19%-116.98%-81.34%-78.62%-57.08%-90.59%-103.91%-128.44%-110.79%-198.84%-422.33%
EBITDA Growth %-25.29%49.55%87.21%-275.12%55.13%35.94%-100.34%39.43%12.93%6.28%27.55%17.32%29.32%23.59%28.7%57.62%13.28%-0.89%53.03%-428.4%
D&A (Non-Cash Add-back)8.28K2.32K170.86K37.02K37.02K37.02K134.97K135.06K135.03K135.23K142.05K139.09K137.26K131.04K429.81K50.13K50.88K1.33M63.52K131.16K
EBIT-2.01M-1.01M-1.21M-9.54M-7.19M-2.03M-6.44M-3M-3.69M-3.25M-3.37M-4.32M-4.31M-3.31M-4.77M-5.11M-5.83M-5.68M-6.07M-12.07M
Net Interest Income-244.46K-902.9K3.26M-345.67K-1.3M-1.62M-4.77M-1.72M-1.64M-1.42M-2.63M-1.35M-1.3M-414.78K-22.75K-66.03K-70.76K-85.88K-101.09K-99.6K
Interest Income6000001.57K7365033329663481.32K03.2K1582.71K00527
Interest Expense244.47K902.9K-3.26M345.67K1.3M1.62M4.78M1.72M1.64M1.42M2.63M1.35M1.3M414.78K25.95K66.19K73.47K85.88K101.09K100.13K
Other Income/Expense-1.03K-1.13M-1.34M-341.37K-6.86M-1.62M-2.6M-2.05M-1.64M-1.42M-2.71M-1.35M-1.39M-274.38K-22.75K-66.03K-70.76K-85.88K-20.71K-97.66K
Pretax Income-2.01M-2.14M-2.32M-9.89M-8.49M-3.65M-9.04M-4.72M-5.33M-4.67M-5.99M-5.67M-5.61M-3.73M-4.79M-5.18M-5.9M-5.77M-6.17M-12.17M
Pretax Margin %--50579.28%635.17%---832.92%-1542.85%-480.68%-508.86%-303.17%-222.96%-110.23%-107.99%-64.05%-100.04%-106.29%-131.14%-146.94%-201.59%-430.43%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-2.05M-2.14M-3.21M-9.89M-8.49M-3.65M-9.04M-4.72M-5.33M-4.67M-5.99M-5.67M-5.61M-3.73M-4.79M-5.18M-5.87M-5.99M-6.1M-12.19M
Net Margin %--50579.28%877.66%---832.92%-1542.85%-480.68%-508.86%-303.17%-222.96%-110.23%-107.99%-64.05%-100.04%-106.29%-130.57%-152.66%-199.11%-431.21%
Net Income Growth %75.81%41.47%64.54%-109.47%-59.44%21.85%-50.8%16.76%5.05%-25.25%-25.05%-9.53%4.5%37.79%21.37%57.54%10.46%-34.94%72.99%-485%
Net Income (Continuing)-2.01M-2.14M-2.32M-9.89M-8.49M-3.65M-9.04M-4.72M-5.33M-4.67M-5.99M-5.67M-5.61M-3.73M-4.79M-5.18M-5.9M-5.77M-6.17M-12.17M
Discontinued Operations-46.39K00000000000000025.42K-224.58K76.14K-22.08K
Minority Interest00000000000000000000
EPS (Diluted)-0.67-2.20-5.88-18.04-17.88-7.88-22.64-14.20-0.44-0.40-0.56-0.13-0.13-0.11-0.12-0.22-0.25-0.17-0.20-0.40
EPS Growth %96.25%72.08%74.03%-27.04%-3963.64%-1870%-3942.86%-10823.08%-238.46%-263.64%-366.67%40.91%48%35.29%40%45%-13.64%-6.25%82.76%-233.33%
EPS (Basic)-0.67-2.20-5.88-18.04-17.88-7.88-25.20-14.20-0.44-0.40-0.56-0.13-0.13-0.11-0.12-0.23-0.25-0.17-0.20-0.40
Diluted Shares Outstanding3.06M544.6K544.6K547.88K474.97K464.3K399.45K326.7K306.97K279.96K272.77K42.81M42.06M37.39M41.09M38.86M38.7M35.19M30.52M30.52M
Basic Shares Outstanding3.06M544.6K544.6K547.88K474.97K464.3K358.99K326.7K306.97K279.96K272.77K42.81M42.06M37.39M41.09M37.36M38.7M35.19M30.52M30.42M
Dividend Payout Ratio--------------------